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Summary High density lipoprotein (HDL) can be 
quantitated by measurement of cholesterol in supernates 
after precipitation of low and very low density lipoprotein 
(LDL and VLDL) with heparin and Mn2+. Supernatant 
turbidity, often observed with hypertriglyceridemic speci- 
mens, indicates incomplete sedimentation of LDUVLDL 
and precludes accurate quantitation of HDL. Ten Lipid 
Research Clinic Laboratories compared an ultrafiltration 
technique for clearing turbid heparin-Mn2+ supernates to 
current methods involving repeat precipitation of either 
the original specimen after dilution or the d > 1.006 g/ml 
fraction after removal of VLDL from the initial specimen 
by ultracentrifugation. Results for ultrafiltration of 429 
turbid supernates averaged only slightly higher (1.0- 1.1 
mg/dl) than results by the dilution or ultracentrifugation 
methods on the same specimens, but this difference was 
Abbreviations: HDL, LDL, VLDL, high, low, and very low den- 
sity lipoproteins, respectively; apoA-I, apolipoprotein A-I, the 
major protein constituent of HDL; apoB, apolipoprotein B, a 
major protein constituent of LDL and VLDL. 
found to be significant (P < 0.005). The agreement of the 
ultrafiltration method with the other two methods is indi- 
cated by the following linear regression equations: a),  
ultrafiltration = (0.964 x ultracentrifugation) + 2.4 mg/dl, 
and correlation coefficient = 0.926; and b), ultrafiltration 
= (0.936 x dilution) + 3.3 mg/dl, and correlation coef- 
ficient = 0 . 9 3 3 . 1  We conclude that ultrafiltration of turbid 
heparin-Mn2+ supernates is a convenient alternative to 
precipitation after either dilution or removal of VLDL.- 
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Garcia, C. Breckinridge, K. Kuba, S. McNeely, G.  Hiller- 
man, P. King, R. Muesing, B. Most, and K. Lippel. Multi- 
laboratory evaluation of an ultrafiltration procedure for 
high density lipoprotein cholesterol quantification in turbid 
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HDL is frequently quantitated as cholesterol 
remaining in the supernatant solution after precipita- 
tion of VLDL and LDL with heparin-Mn2+ (1,  2).  A 
major source of error associated with this method has 
been incomplete sedimentation of the insoluble lipo- 
protein complex which is manifest by turbidity in 
the supernatant solution. Incomplete sedimenta- 
tion occurs in approximately 10% of plasma speci- 
mens, primarily those with hypertriglyceridemia (3). 
That this turbidity in supernates is associated with 
contamination of the HDL fraction by LDWVLDL is 
indicated by the presence of apoB, the major protein 
of VLDL and LDL. The  insoluble heparin-Mn2+ lipo- 
protein complex of a specimen with elevated triglyc- 
eride has a low protein to lipid ratio and hence a 
low density. When the density of the complex is near 
that of the solution, the complex may not sediment 
under the usual centrifugation conditions. In speci- 
mens with substantially elevated triglyceride values, 
the heparin-Mn'+ lipoprotein complex may actually 
float and form a layer at the surface of a clear in- 
franatant solution. Previous studies have shown that 
such a clear infranatant solution is essentially free of 
VLDL and LDL (4). Therefore, the turbidity observed 
in some supernates is primarily a result of incomplete 
sedimentation of the insoluble lipoprotein complex 
rather than of incomplete lipoprotein precipitation. 
Various methods have been used to circumvent the 
problem of supernatant turbidity. One approach has 
been to dilute the hypertriglyceridemic specimen 
prior to heparin-Mn2+ precipitation (1). This in- 
creases the concentrations of heparin and Mn2+ 
relative to that of VLDL/LDL while simultaneously 
decreasing the solution density, thus facilitating 
sedimentation. A second approach has been to remove 
the triglyceride rich-VLDL (and chylomicrons, if 
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present) by ultracentrifugation prior to heparin-Mn2+ 
precipitation (2). A third alternative is to remove the 
insoluble lipoprotein complex by subjecting the 
turbid supernates to an appropriate ultrafiltration 
method (3). This paper describes an evaluation com- 
pleted in ten Lipid Research Clinics Laboratories of 
such an ultrafiltration technique using 0.22 pm 
filters. This ultrafiltration procedure is compared with 
the dilution method and with the method involving 
removal of VLDL prior to centrifugation. In addition, 
the overestimation of HDL cholesterol associated 
with various degrees of supernatant turbidity is 
quantified. 
METHODS 
According to standardized Lipid Research Clinic 
protocols (2), HDL was quantitated by measurement 
of cholesterol in supernates of EDTA plasma after 
removal of other lipoproteins by precipitation with 
heparin and Mn2+ (4, 5). Specimens giving turbid 
supernates were again precipitated after dilution of 
the original specimen with an equal volume of 0.15 M 
NaCl solution (2). Alternatively, VLDL was removed 
from the original specimen by centrifugation at 
105,OOOg for 18 hr and the heparin-Mn2+ precipita- 
tion was repeated on the VLDL-free (d > 1.006 g/ml) 
fraction adjusted to the original plasma volume (2). 
Cholesterol was quantified in isopropyl alcohol ex- 
tracts of EDTA plasma specimens and HDL super- 
nates by a Lieberman-Burchard reagent method (2) 
for the AutoAnalyzer I1 (Technicon Instruments, 
Inc., Tarrytown, NY). Triglycerides were quanti- 
fied simultaneously by the Kessler procedure (6). 
An alternative approach to HDL quantitation in 
turbid heparin-Mn2+ supernates, the evaluation of 
which is the subject of this report, involved ultrafiltra- 
tion of turbid supernates as described previously (3). 
Briefly, a 25-mm Swinnex holder was assembled with 
a 0.22 pm Millipore filter protected by an AP 15 and an 
AP 20 depth prefilter of 22 mm diameter fitted within 
the silicone gasket (Millipore Corp. Bedford, MA). 
Turbid supernates were poured into a 5-ml syringe 
attached to the top of the filter assembly. The 
syringe plunger was inserted and the supernate was 
forced through the filter with moderate pressure. 
The ten participating laboratories were each re- 
quested to perform the ultrafiltration procedure on 
approximately 50 turbid heparin-Mn2+ supernates 
selected from their routine workload. On approxi- 
mately 30 of the specimens in each laboratory, ultra- 
filtration was to be compared to the dilution pro- 
cedure. The original plasma specimen was diluted 
with an equal volume of 0.15 M NaCl solution and 
then treated with heparin and Mn2+ solutions as de- 
scribed. Ultrafiltration was to have been compared 
to precipitation of the VLDL-free (d > 1.006 g/ml) 
specimens on approximately 30 additional specimens 
by each laboratory. In this instance, the turbid super- 
nate was filtered immediately. The d > 1.006 g/ml 
fraction was obtained after overnight ultracentrifuga- 
tion of the original specimen and was treated with 
the heparin and MnZ+ solutions. Therefore, all three 
separation methods were compared by each labora- 
tory on approximately ten of the specimens. 
In each laboratory, supernates and filtrates for a 
single specimen were analyzed for cholesterol se- 
quentially in duplicate with the second value of each 
duplicate used for comparison to minimize the sample 
interaction effects on the AutoAnalyzer (3). Choles- 
terol results were corrected for dilution. Analytical 
performance in quantitation of HDL cholesterol has 
been reported (7). The results were initially compiled 
at the Northwest Lipid Research Laboratory and were 
analyzed statistically by the Central Patient Registry 
(Chapel Hill, NC) for the Lipid Research Clinics 
Program. 
Each laboratory was requested to indicate the type 
of supernatant turbidity based on the following 
categories that are obviously somewhat subjective: 1 ) 
small, granular particles floating on the surface of a 
clear supernatant solution; 2) an oily, chylomicron- 
like ring or layer of insoluble material at the surface 
of a clear solution; 3 ) slight turbidity throughout the 
supernatant solution; and 4 ) obvious or pronounced 
turbidity throughout the supernatant solution. Super- 
nates with an oily layer on the surface but with 
turbidity throughout the solution were included in 
category 4 .  In categories 1 -3 most and in category 4 
some of the insoluble lipoprotein complex was 
sedimented, forming a pellet at the bottom of the tube. 
In separate experiments performed at the North- 
west Lipid Research Laboratory, the amount of apoB- 
associated (non-HDL) lipoprotein present in the 
various categories of turbid supernate was estimated 
by measuring cholesterol and apoB-associated choles- 
terol in turbid supernates before and after ultra- 
filtration. In addition, filtration performance with 
cellulose acetate filters (Celotate, Millipore Corp.) was 
compared to that using the usual Millipore filter, 
which is composed of mixed esters of cellulose 
acetate and nitrate. ApoA-I and apoB levels were 
measured by previously described radial immuno- 
diffusion methods with specific antibodies to apoA-I 
and apoB, respectively. ApoB was quantitated as 
apoB-associated cholesterol by reference to a standard 
prepared from pooled human plasma fractions of 
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d > 1.006 g/ml of known LDL cholesterol content 
(3, 8, 9). 
RESULTS AND DISCUSSION 
Ten North American Laboratories of the Lipid 
Research Clinics Program participated in the collabo- 
rative evaluation of the ultrafiltration technique. The 
ultrafiltration method was compared on a total of 
429 specimens, all of which exhibited turbid super- 
nates as defined above after heparin-Mn2+ pre- 
cipitation. Plasma cholesterol values on these speci- 
mens ranged from 144 to 1405 mg/dl with a mean of 
290 mg/dl and a standard deviation of 105 mg/dl. 
Total triglyceride values ranged from 45 to 10,560 
mg/dl with a mean of 565 mg/dl and a standard 
deviation of 880 mg/dl. Only 29.6% (127) had total 
triglyceride values of less than 300 mg/dl, and 3.7% 
(16) had total triglyceride values of less than 150 mg/ 
dl. In 50.8% (218 of 429) of the specimens, ultra- 
filtration was compared to precipitation of the 
d > 1.006 g/ml fraction, and in 72.3% (310) ultra- 
filtration was compared to the dilution method. All 
three methods were compared on 22.8% (98) of the 
specimens. 
Categories of supernatant turbidity were defined 
as described in Methods. Of the 429 turbid super- 
nates, 3 13 were categorized by these criteria; some 
participating laboratories did not categorize turbidity. 
Thirteen percent (41) were in category I ,  25.9% (81) 
in category 2, 22.7% (71) in category 3 ,  and 38.3% 
(120) in category 4.  The mean plasma total triglyc- 
eride values for specimens with supernates in each 
category were 283, 660, 309, and 720 mg/dl for cate- 
gories I, 2, 3, and 4 ,  respectively. 
The results for HDL cholesterol quantification by 
ultrafiltration of turbid supernates compared to pre- 
cipitation of the d > 1.006 fractions for the same 
specimens are presented in Fig. 1A. The linear 
regression relationship was as follows: ultrafiltration 
= (0.964 x ultracentrifugation) + 2.375 mg/dl, with 
a correlation coefficient of 0.926. The overall choles- 
terol mean by ultrafiltration was 36.17 mg/dl com- 
pared to 35.06 mg/dl for precipitation of the d > 1.006 
g/ml fraction. This difference, 1.1 1 mg/dl, while small, 
was statistically significant at P < 0.005 ( t  = 3.06) by 
Student’s paired t-test. The average between-method 
differences in individual laboratories ranged from 0.1 
to 3.2 mg/dl. The ultrafiltration values averaged 
higher than the ultracentrifugation values in every 
laboratory with the exception of one, which observed 
Ctmbslaol (mg/dll in hf”.Mn’’ Supmnmes ol d > l W  F r r t i o n  Chokterd ImgdI) in H w r i n  Mn’. Supernales of Diluted Specmh”en 
Fig. 1. Panel A ,  Cholesterol in 218 heparin-Mn2+ supernates of d > 1.006 g/ml (VLDL-free) fractions (x) compared to 0.22 pm 
filtrates (y)  of turbid heparin-Mn2+ supernates for the corresponding plasma specimens. The linear regression parameters for the solid line 
are y = (0.964 X ultracentrifugation) + 2.375 mg/dl, with a correlation coefficient of 0.926. The dotted line illustrates y = x or the line of 
perfect agreement. Panel B, Cholesterol in 3 10 heparin-Mn2+ supernates of specimens precipitated after dilution with an equal volume of 
0.15 M NaCl solution (x) compared to 0.22 pm filtrates (y) of turbid heparin-Mn2+ supernates for the same specimens without dilution. The 
linear regression relationship is described by y = (0.936 X dilution) + 3.323 mg/dl, with a correlation coefficient of 0.933. 
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TABLE 1. Comparison of three methods for turbid heparin-Mn2+ supernates: ultrafiltration (UF),  
precipitation of d > 1.006 giml plasma fraction (B), and precipitation of diluted plasma (D)" 
Cholesterol in nrgidl 
~ ~~~ 
Linear Regression Parameters 
Correlation 
Slope Intercept Coefficient p. ' . Mean X Mean Y S.D." m e d  1' 
~~ ~~ 
UF (Y)  versus B (X)  35.0 36.4 4.88 1.96d 0.94 3.48 0.873 
UF (Y) versus D (X)  35.5 36.4 4.07 1.54'' 0.95 2.50 0.9 12 
D (Y)  versus B (X)  35.0 35.5 3.92 0.85" 0.94 2.76 0.910 
' I  Comparison on 98 samples tested by all three methocl5. 
Paired Standard Deviation = (Z difference */21i)"~. 
Student's paired t test. 
'' Difference not significant at P < 0.05 
an average 1.0 mg/dl difference in the opposite 
direction. 
The  comparison of ultrafiltration with dilution is 
presented in Fig. 1B. The  agreement between methods 
is indicated by the linear regression parameters: 
ultrafiltration = (0.936 x dilution) + 3.323 mgidl 
with a correlation coefficient of 0.933. The  mean 
cholesterol by ultrafiltration was 37.7 1 mg/dl com- 
pared to 36.74 mg/dl for dilution. The  between- 
method difference was again slight, 0.93 mgidl, but 
statistically significant at P < 0.005 ( t  = 4.37). Aver- 
age differences in individual laboratories ranged from 
0.1 mg/dl to 2.0 mg/dl. Values by ultrafiltration 
averaged higher than those by dilution in every labo- 
ratory except one which observed an average dif- 
ference of 0.6 mg/dl in the opposite direction. 
These results suggest excellent correlation and 
agreement between the ultrafiltration method and 
either precipitation of the d > 1.006 g/ml fraction or 
precipitation of the specimen after dilution. The  
small differences observed between the methods were, 
nevertheless, statistically significant because of the 
excellent precision obtained in the cholesterol meas- 
urement. Because the between-method differences 
were statistically significant, results for specimens 
tested by all three methods were compared to deter- 
mine whether the difference between ultrafiltration 
and either precipitation of the d > 1.006 g/ml plasma 
fraction or  the diluted sample was greater than the 
difference observed between the latter two methods. 
Results from this comparison, obtained for a subset of 
98 specimens, are shown in Table 1. On these speci- 
mens, the mean cholesterol by ultrafiltration was 
36.4 mg/dl compared to 35.0 mg/dl for precipitation 
of the d > 1.006 g/ml fraction and 35.5 mg/dl for 
dilution. None of the between-method differences on 
this subset were statistically significant at P < 0.05. 
The  linear regression slopes, intercepts, and correla- 
tion coefficients (Table 1) for these comparisons were 
similar. 
In other experiments performed at the Northwest 
Lipid Kesearch Laboratory, the extent of overesti- 
mation of HDL cholesterol associated with the various 
categories of supernatant turbidity was determined 
by measuring cholesterol and apoB-associated choles- 
terol in turbid heparin-Mn2+ supernates and in 
clear filtrates of the same supernates (Table 2). Super- 
nates in the first category contained relatively little 
apoB-associated cholesterol and filtration removed 
on the average only 2.1 mg/dl cholesterol. ApoB- 
associated cholesterol in filtrates averaged 1.4 mg/dl 
compared to 1.7 mg/dl in the supernates. Therefore, 
TABLE 2 .  Mean cholesterol and apoB-associated (non-HDL) cholesterol values in turbid 
heparin-Mn*+ supernates and in their clear filtrates 
Turbid Supernate Clear Filtrate 
Category Supernatant Appearance" I1 Cholesterol apoBb Cholesterol apoBb 
1 
2 
3 Slight turbidity throughout supernatant 
4 Pronounced turbidity throughout 
Granular particles at surface of clear 
Oily layer or ring at surface of clear 
supernate 1 1  50.4 nig/dl 1.7 mg/dl 48.3 mg/dl 1.4 mg/dl 
supernate 9 49.1 5.1 44.6 1.6 
solution 7 56.6 10.5 43.8 0.2 
supernatant solution 6 127.2 >30.3' 34.3 1.4 
a As defined in Methods. 
* ApoB-associated cholesterol by radial immunodiffusion assay with specific anti-apoB sera. 
Some levels exceeded assay range. 
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filtration of these supernates removed virtually no 
apoB-associated cholesterol. The cholesterol loss with 
filtration was comparable to that previously reported 
for filtration of clear supernates, which is probably 
explained by lipoprotein adsorption on the ultra- 
filtration membranes (3). The low apoB-associated 
cholesterol values in category 1 supernates were 
similar to those reported for clear heparin-Mn2+ 
supernates. Filtration of nine category 2 supernates 
removed an average of 4.5 mg/dl cholesterol. ApoB- 
associated cholesterol averaged 5.1 mg/dl in the initial 
supernates compared to 1.6 mg/dl in their filtrates. 
These particular specimens had only moderate 
amounts of apoB-associated lipoproteins at the sur- 
face; most of the insoluble lipoprotein complex had 
sedimented. In other similar supernates, contamina- 
tion could be much greater depending on the VLDL 
and chylomicron levels. With extremely hypertriglyc- 
eridemic specimens, virtually all of the insoluble 
lipoprotein complex may layer at the surface during 
centrifugation. 
Supernates in category 3 (Table 2), with slight 
turbidity throughout the solution, contained an 
average of 10.5 mg/dl apoB-associated cholesterol and 
their filtrates averaged 0.2 mg/dl. Filtration removed 
on the average 12.8 mg/dl cholesterol. Category 4 
supernates, with pronounced turbidity, were exten- 
sively contaminated with apoB-associated lipopro- 
teins. Some supernates exceeded the linear range of 
the radial immunodiffusion method (>30 mg/dl) and 
an average of 92.9 mg/dl cholesterol was removed by 
the filtration process. Filtrates averaged 1.4 mg/dl 
apoB-associated cholesterol. 
These results confirm that supernatant turbidity 
indicates contamination by the apoB-associated lipo- 
proteins and demonstrate that the apoB-associated 
cholesterol in supernates is related to their degree 
of turbidity. Cholesterol measurement in supernates 
with turbidity or an oily layer at the surface would 
generally substantially overestimate HDL. Therefore, 
supernates that are not clear require further manip- 
ulation to separate the apoB-associated lipopro- 
teins. The ultrafiltration technique removed virtually 
all of the apoB-associated lipoproteins, regardless of 
the degree of initial supernatant turbidity. 
However, the small granular particles that are 
sometimes observed at the surface of a clear heparin- 
Mn2+ supernate appear to contain negligible apoB- 
associated lipoprotein cholesterol and do not neces- 
sitate ultrafiltration for accurate quantitation of HDL. 
It should also be noted that supernates that are al- 
lowed to stand at room temperature may develop a 
slight cloudiness due to formation of an insoluble 
(non-lipoprotein) manganese complex (4). It is impor- 
tant, therefore, to distinguish between supernates 
that are turbid immediately upon removal from the 
centrifuge and those that become turbid after standing 
at room temperature. This can be done by screening 
samples for turbidity immediately after centrif- 
ugation. 
Filtration of turbid heparin-Mn2+ supernates was 
tested with the Celotate (cellulose acetate) mem- 
branes, which reportedly have less tendency to 
adsorb protein than the standard Millipore filters. Re- 
sults on 12 samples indicated that more apoA-I was 
removed by the Celotate membrane (mean filtrate 
apoA-I = 90.3 mg/dl) than by the Millipore (mean 
filtrate apoA-I = 116.5 mg/dl). In addition, the apoB- 
associated cholesterol level in the Celotate filtrates 
averaged slightly higher than that of the Millipore 
filtrates (2.4 versus 1 .O mg/dl). Therefore, separation 
by the Millipore filter appeared to be more specific 
than that by the Celotate filter for this application. 
One disadvantage of the 25-mm filtration apparatus 
is the relatively large void volume. This necessitated 
filtering at least 1.5 ml of supernate to obtain suf- 
ficient material for analysis. We tested 13-mm 
Swinnex holders (Millipore Corp.) that were assem- 
bled with 0.22 pm filters and two depth pre-filters. 
This size of filter, unfortunately, had a greater 
tendency to plug during filtration reducing flow rates 
and retaining HDL. Therefore, the smaller filter did 
not appear suitable for filtration of most turbid 
supernates. 
In summary, these results confirm the effective- 
ness of the filtration technique for clearing turbid 
heparin-Mn2+ supernates. Cholesterol results are 
comparable to those by either the dilution method or 
the ultracentrifugation procedure, which are presently 
used for quantitating HDL in hypertriglyceridemic 
specimens. Ultrafiltration removes virtually all of the 
apoB-associated lipoproteins, regardless of the degree 
of supernatant turbidity. The particular ultrafiltra- 
tion apparatus as described previously and evaluated 
here appears optimal for clearing turbid supernates. 
In this evaluation, ultrafiltration was performed on 
supernates obtained by heparin-Mn2+ at 46 mM final 
concentration as prescribed in Lipid Research Clinics 
protocol. A modified procedure with Mn2+ at 92 mM 
has been demonstrated to give a substantially smaller 
proportion of turbid supernates (5). In addition, this 
ultrafiltration procedure was previously demon- 
strated to similarly remove apoB-associated lipopro- 
teins from supernates turbid after precipitation at 
the higher Mn2+ concentration (3).m 
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